HEXELECT
Genmab B.V.
Application Filed: 2018-11-15
Trademark Application Details
PUBLISHED FOR OPPOSITION
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79253307 |
| Registration Number | 5952365 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Mark Lerner Esq. |
| Attorney Docket Number | 106961-0014 |
| Law Office Assigned | L80 |
| Employee Name | EBAUGH, MICHAEL THOMAS |
Timeline
| 2018-11-15 | Application Filed |
| 2019-09-18 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-10-22 | Published for Opposition |
| 2019-10-22 | Status: Live/Pending |
| 2019-10-22 | Transaction Date |
| 2020-01-07 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Genmab B.V. |
| Address | Uppsalalaan 15 NL-3584 CT Utrecht NL |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | NL |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals |
| GS0011 | Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2019-02-28 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-03-05 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2019-03-05 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2019-03-08 | 4 CNRT R:Renewal |
| APPLICATION FILING RECEIPT MAILED | 2019-03-09 | 5 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2019-03-09 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2019-03-20 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2019-03-20 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2019-04-06 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-08-26 | 10 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2019-08-31 | 11 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-08-31 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-08-31 | 13 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2019-09-13 | 14 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2019-09-13 | 15 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2019-09-13 | 16 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2019-09-13 | 17 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-09-16 | 18 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-10-02 | 19 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2019-10-02 | 20 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2019-10-02 | 21 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2019-10-19 | 22 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2019-10-22 | 23 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-10-22 | 24 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-01-07 | 25 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-04-07 | 26 FICR P: |
| FINAL DISPOSITION PROCESSED | 2020-04-18 | 27 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2020-04-18 | 28 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-05-08 | 29 FINO P: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2024-06-05 | 30 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2024-06-05 | 31 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2024-06-05 | 32 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2024-06-05 | 33 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2024-06-05 | 34 TCCA I:Incoming Correspondence |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2024-06-05 | 35 EWAF I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 